Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure

Transplantation Proceedings

Volumn 36, Issue 10, 2004, Pages 2993-2996

  He, X ^a,b   Johnston, A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b U Med Dent Schools Guys C   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; DEATH; GRAFT FAILURE; GRAFT SURVIVAL; HEALTH SURVEY; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SAFETY; ACUTE DISEASE; CHRONIC DISEASE; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; KIDNEY TRANSPLANTATION; MORTALITY; PATHOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; SURVIVAL; TIME; TREATMENT FAILURE;

ACUTE DISEASE; CHRONIC DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT FAILURE;

EID: 21244487524     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.10.070     Document Type: Article

References (22)

1. Almond PS, Matas A, Gillingham K, et al: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55:752, 1993
2. Tesi RJ, Elkhammas EA, Henry ML, et al: Acute rejection episodes: best predictor of long-term primary cadaveric renal transplant survival. Transplant Proc 25:901, 1993
3. Massy ZA, Guijarro C, Wiederkehr MR, et al: Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int 49:518, 1996
4. Shaikewitz ST, Chan L: Chronic renal transplant rejection. Am J Kidney Dis 23:884, 1994
5. Perez FM, Rodriguez-Carmona A, Bouza P, et al: The prognostic significance of acute renal failure after renal transplantation in patients treated with cyclosporin. QJM 91:27, 1998
6. Matas AJ, Gillingham KJ, Payne WD, et al: The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 57:857, 1994
7. Pallardo Mateu LM, Sancho CA, Capdevila PL, et al: Acute rejection and late renal transplant failure: Risk factors and prognosis. Nephrol Dial Transplant 19 (Suppl 3):III38, 2004
8. Cueto-Manzano AM, Rojas E, Rosales G, et al: Risk factors for long-term graft loss in kidney transplantation: experience of a Mexican single-center. Rev Invest Clin 54:492, 2002
9. Boratynska M, Szepietowski T, Szewczyk Z: Acute rejection and delayed graft function-risk factors of graft loss. Ann Transplant 1:19, 1996
10. Ferguson R: Acute rejection episodes-best predictor of long-term primary cadaveric renal transplant survival. Clin Transplant 8:328, 1994
11. Joseph JT, Kingsmore DB, Junor BJ, et al: The impact of late acute rejection after cadaveric kidney transplantation. Clin Transplant 15:221, 2001
12. Cole E, Naimark D, Aprile M, et al: An analysis of predictors of long-term cadaveric renal allograft survival. Clin Transplant 9:282, 1995
13. Beckingham IJ, Dennis MJ, Bishop MC, et al: Effect of human leucocyte antigen matching on the incidence of acute rejection in renal transplantation. Br J Surg 81:574, 1994
14. Kobayashi T, Yokoyama I, Uchida K, et al: The significance of HLA-DRBI matching in clinical renal transplantation. Transplantation 54:238, 1992
15. Cecka JM: Outcome statistics of renal transplants with an emphasis on long-term survival. Clin Transplant 8:324, 1994
16. Sumrani N, Delaney V, Daskalakis P, et al: The detrimental effect of early rejection on long-term renal allograft outcome. Transplant Proc 24:1750, 1992
17. Sijpkens YW, Doxiadis II, Mallat MJ, et al: Early versus late acute rejection episodes in renal transplantation. Transplantation 75:204, 2003
18. Toma H, Tanabe K, Tokumoto T, et al: Time-dependent risk factors influencing the long-term outcome in living renal allografts: donor age is a crucial risk factor for long-term graft survival more than 5 years after transplantation. Transplantation 72:940, 2001
19. He X, Johnston A: Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss? Transplant Proc 36:1321, 2004
20. Jorga A, Holt DW, Johnston A: Therapeutic drug monitoring of cyclosporine. Transplant Proc 36:396S, 2004
21. Cole E, Midtvedt K, Johnston A, et al: Recommendations for the implementation of Neoral C(2) monitoring in clinical practice. Transplantation 73:S19, 2002
22. Belitsky P, Dunn S, Johnston A, et al: Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients. Clin Pharmacokinet 39:117, 2000